Biotech Breakthroughs

Results

56

1 new

Biotech stocks worldwide which are expected to become profitable in the next 3 years.

56 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
	MDGL	US$546.88	1.7%	88.7%	US$12.4b	US$680.60	11.1	59.2%	n/a	Pharmaceuticals & Biotech
	SNDX	US$19.22	-9.4%	93.8%	US$1.7b	US$39.45	7.8	68.1%	n/a	Pharmaceuticals & Biotech
	MRKR	US$1.11	-10.5%	-19.6%	US$19.7m	US$7.87	5.2	69.0%	n/a	Pharmaceuticals & Biotech
	ANAB	US$52.14	-0.9%	108.7%	US$1.5b	US$87.09	6.6	48.1%	43.2%	Pharmaceuticals & Biotech
	ARDX	US$5.00	-1.6%	15.2%	US$1.3b	US$16.30	2.9	56.0%	n/a	Pharmaceuticals & Biotech
	ACHV	US$6.18	-2.1%	131.3%	US$634.4m	US$13.80	59.4	64.3%	n/a	Pharmaceuticals & Biotech
	FRMM	US$5.29	-7.2%	-85.0%	US$70.3m	US$9.50	7.4	127.7%	n/a	Pharmaceuticals & Biotech
	RNXT	US$0.90	3.8%	-25.2%	US$40.9m	US$7.03	27.2	73.0%	n/a	Pharmaceuticals & Biotech
	LCTX	US$1.06	-4.5%	2.9%	US$266.7m	US$5.50	17.9	72.2%	n/a	Pharmaceuticals & Biotech
	CAPR	US$6.57	-66.9%	-19.7%	US$380.5m	US$40.80	1.4	63.6%	n/a	Pharmaceuticals & Biotech
	TNYA	US$0.74	-4.9%	8.7%	US$159.5m	US$4.00	709.0	60.9%	n/a	Pharmaceuticals & Biotech
	NTLA	US$10.80	-2.7%	-7.2%	US$1.5b	US$26.17	22.8	67.9%	n/a	Pharmaceuticals & Biotech
	ARQT	US$27.86	-0.1%	91.1%	US$3.6b	US$34.63	8.4	48.1%	n/a	Pharmaceuticals & Biotech
	LGVN	US$0.59	-5.0%	-62.3%	US$19.0m	US$7.15	15.5	55.5%	n/a	Pharmaceuticals & Biotech
	VRDN	US$19.88	3.7%	11.7%	US$2.2b	US$36.13	31.0	60.9%	n/a	Pharmaceuticals & Biotech
	CTOR	US$0.54	-6.4%	-75.2%	US$50.3m	US$4.00	8.9	59.9%	n/a	Pharmaceuticals & Biotech
	CGON	US$69.12	-0.3%	156.9%	US$6.4b	US$90.69	1202.2	61.1%	n/a	Pharmaceuticals & Biotech
	ACIU	US$2.27	1.3%	5.1%	US$225.2m	US$8.56	49.6	47.1%	n/a	Pharmaceuticals & Biotech
	HUMA	US$0.62	-3.1%	-74.3%	US$170.1m	US$2.05	83.5	60.9%	n/a	Pharmaceuticals & Biotech
	MNOV	US$1.29	-3.0%	-4.4%	US$65.5m	US$9.00	106.4	66.7%	n/a	Pharmaceuticals & Biotech
	NAMS	US$27.91	-8.6%	28.0%	US$3.3b	US$50.83	144.6	64.3%	n/a	Pharmaceuticals & Biotech
	VERA	US$32.51	-10.6%	56.4%	US$2.3b	US$81.79	4.7	63.8%	n/a	Pharmaceuticals & Biotech
	INSM	US$103.12	-3.3%	-2.0%	US$22.6b	US$196.18	27.3	67.6%	n/a	Pharmaceuticals & Biotech
	LRMR	US$3.63	-9.7%	1.7%	US$399.8m	US$14.40	2.4	52.5%	n/a	Pharmaceuticals & Biotech

Page 1 of 2